NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
Apr 17 04:00PM ET
8.44
Dollar change
-3.11
Percentage change
-26.93
%
Index- P/E- EPS (ttm)-2.59 Insider Own86.98% Shs Outstand6.03M Perf Week-25.31%
Market Cap53.32M Forward P/E- EPS next Y- Insider Trans111.75% Shs Float0.82M Perf Month-34.57%
Income-9.70M PEG- EPS next Q- Inst Own0.41% Short Float4.18% Perf Quarter-5.06%
Sales0.50M P/S106.64 EPS this Y- Inst Trans0.65% Short Ratio0.66 Perf Half Y275.11%
Book/sh1.12 P/B7.51 EPS next Y- ROA-72.84% Short Interest0.03M Perf Year165.83%
Cash/sh1.98 P/C4.26 EPS next 5Y- ROE-197.92% 52W Range1.44 - 36.00 Perf YTD-38.26%
Dividend Est.- P/FCF- EPS past 5Y41.35% ROI-80.94% 52W High-76.56% Beta3.93
Dividend TTM- Quick Ratio4.45 Sales past 5Y1409.42% Gross Margin-64.80% 52W Low486.11% ATR (14)1.38
Dividend Ex-Date- Current Ratio4.45 EPS Y/Y TTM76.04% Oper. Margin-989.80% RSI (14)30.49 Volatility14.68% 10.31%
Employees7 Debt/Eq0.88 Sales Y/Y TTM-97.70% Profit Margin-1940.20% Recom3.00 Target Price10.00
Option/ShortNo / Yes LT Debt/Eq0.77 EPS Q/Q-38.64% Payout- Rel Volume1.04 Prev Close11.55
Sales Surprise- EPS Surprise- Sales Q/Q- EarningsMar 18 AMC Avg Volume51.88K Price8.44
SMA20-32.44% SMA50-25.36% SMA2005.21% Trades Volume65,441 Change-26.93%
Date Action Analyst Rating Change Price Target Change
Dec-13-21Downgrade Chardan Capital Markets Buy → Neutral $2.25 → $0.40
Dec-18-20Initiated BMO Capital Markets Outperform $6
Nov-20-19Initiated Guggenheim Buy $9
Apr-14-25 06:11PM
Apr-11-25 07:42PM
Mar-18-25 04:01PM
Mar-13-25 04:08PM
Jan-23-25 12:17AM
04:01PM Loading…
Jan-22-25 04:01PM
Dec-26-24 08:08PM
Dec-21-24 01:48PM
Dec-20-24 04:42PM
Nov-14-24 04:01PM
Sep-18-24 04:01PM
Sep-09-24 06:53PM
Aug-26-24 09:08AM
Aug-19-24 10:31AM
Aug-15-24 10:31AM
04:01PM Loading…
Aug-13-24 04:01PM
Aug-08-24 04:27PM
Aug-02-24 07:34AM
Aug-01-24 04:01PM
Jul-26-24 07:36AM
Jun-17-24 09:53PM
04:01PM
Jun-06-24 09:52PM
04:01PM
May-29-24 07:39AM
May-23-24 04:01PM
May-16-24 09:52PM
04:08PM
Apr-22-24 04:01PM
Feb-06-24 07:05AM
04:01PM Loading…
Feb-05-24 04:01PM
Dec-08-23 08:40AM
Nov-28-23 04:01PM
Aug-23-23 09:48AM
Aug-11-23 04:01PM
Jul-14-23 04:01PM
May-26-23 04:01PM
May-19-23 04:01PM
May-04-23 04:01PM
Apr-27-23 07:00AM
Mar-27-23 04:01PM
Feb-24-23 05:10PM
Dec-14-22 05:00AM
Nov-14-22 04:01PM
Sep-26-22 04:01PM
Sep-01-22 07:00AM
Aug-15-22 04:01PM
Jul-20-22 04:01PM
Jun-29-22 12:00PM
May-27-22 04:01PM
May-17-22 07:00AM
May-16-22 04:01PM
May-10-22 07:21PM
May-09-22 07:00AM
Mar-25-22 04:15PM
Feb-04-22 11:25AM
07:00AM
Jan-05-22 01:38PM
Dec-31-21 07:07PM
06:02PM
02:53PM
01:15PM
Dec-30-21 05:57PM
03:31PM
10:00AM
Dec-29-21 11:46PM
05:57PM
04:30PM
10:45AM
Dec-28-21 05:57PM
02:50PM
10:00AM
Dec-27-21 03:16PM
11:00AM
Dec-26-21 08:32AM
Dec-24-21 06:13PM
01:56PM
10:40AM
Dec-23-21 08:38PM
09:30AM
Dec-22-21 06:22PM
05:59PM
04:50PM
02:32PM
11:00AM
10:00AM
Dec-21-21 05:54PM
04:08PM
11:00AM
09:30AM
07:38AM
Dec-20-21 05:47PM
03:49PM
11:00AM
11:00AM
10:00AM
Dec-19-21 09:00PM
08:32AM
Dec-17-21 06:13PM
05:00PM
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HiTron Systems Inc.10% OwnerDec 26 '24Buy3.002,900,0008,700,0003,333,333Mar 26 05:41 PM
DGP Co., Ltd.10% OwnerSep 12 '24Buy3.00237,223711,669849,223Sep 16 09:41 PM